Novel High-Throughput Microwell Spectrophotometric Assay for One-Step Determination of Lorlatinib, a Novel Potent Drug for the Treatment of Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small Cell Lung Cancer

<i>Background and Objectives:</i> Lorlatinib (LOR) belongs to the third-generation anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors. People who are diagnosed with ALK-positive metastatic and advanced non-small cell lung cancer (NSCLC) are eligible to get it as a first-line treatment optio...

Descripció completa

Dades bibliogràfiques

Autors principals:	Abdullah M. Al-Hossaini, Ibrahim A. Darwish, Hany W. Darwish
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2023-04-01
Col·lecció:	Medicina
Matèries:	2,3-dichloro-3,5-dicyano-1,4-benzoquinone lorlatinib non-small cell lung cancer charge transfer complex spectrophotometry high throughput
Accés en línia:	https://www.mdpi.com/1648-9144/59/4/756
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!